Immunity to SARS-CoV-2: Lessons Learned
In the year since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and with understanding of the etiology of the coronavirus disease 2019 (COVID-19) pandemic, it has become clear that most infected individuals achieve some form of immunity against the virus with relative...
Main Authors: | Jaime Fergie, Amit Srivastava |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.654165/full |
Similar Items
-
Structural Dissection of Viral Spike-Protein Binding of SARS-CoV-2 and SARS-CoV-1 to the Human Angiotensin-Converting Enzyme 2 (ACE2) as Cellular Receptor
by: Deborah Giordano, et al.
Published: (2021-08-01) -
Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages
by: Umesh Kalathiya, et al.
Published: (2021-02-01) -
Serological Test to Determine Exposure to SARS-CoV-2: ELISA Based on the Receptor-Binding Domain of the Spike Protein (S-RBD<sub>N318-V510</sub>) Expressed in <i>Escherichia coli</i>
by: Alan Roberto Márquez-Ipiña, et al.
Published: (2021-02-01) -
Intradermal delivery of receptor‐binding domain of SARS‐CoV‐2 spike protein with dissolvable microneedles to induce humoral and cellular responses in mice
by: Chaiyaporn Kuwentrai, et al.
Published: (2021-01-01) -
Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features
by: Sk. Sarif Hassan, et al.
Published: (2020-12-01)